Glimepiride and Metformin
Strength(s): 0.5 mg + 1000 mg, 0.5 mg + 500 mg,
1 mg + 1000 mg, 1 mg + 850 mg, 1 mg + 500 mg,
2 mg + 1000 mg, 2 mg + 850 mg, 2 mg + 500 mg,
3 mg + 1000 mg, 3 mg + 850 mg,
4 mg + 1000 mg
Dosage
Form: Tablets
Description:
This combination leverages Glimepiride’s insulin-stimulating action and Metformin’s glucose-lowering effects for optimal glycemic control in patients with type 2 diabetes.
Key Features:
- Broad range of strengths for tailored therapy
- Reduces hepatic glucose production and enhances insulin release
- Promotes glycemic stability
Precautions:
Monitor for hypoglycemia, especially in combination therapy. Contraindicated in patients with severe kidney impairment.